Discover more from All Facts Matter
The New Image Of Faucism
Michel Goldman's Cancer Is Damning Proof Of His Own Debasement Of His Own Profession
For the morbidly curious, Faucism’s new look is the full-body CT scan of a lymphoma patient, made that way by two COVID-19 mRNA inoculations and one COVID-19 mRNA “booster” shot. This information comes to us, ironically enough, from a longtime bastion of Faucist fanaticism, The Atlantic.
First a bit of positive news: as of the writing of the article in The Atlantic, the subject, Michel Goldman, appears to be cancer free. Faucist or no, cancer is not a thing to wish on any human being, and I for one am glad for his seeming recovery.
Nevertheless, Michel Goldman, his brother Serge, Roxanne Khamsi, writer for The Atlantic, and every one of their colleagues who have enabled and perpetuated the negligent and malignant pseudo-scientific horse hockey surrounding the mRNA inoculations deserve all the infamy, all the opprobriums, and all of whatever justice, Divine or mortal, will someday be meted out to them for the untold lives these inoculations have damaged and irrevocably altered the way Michel Goldman’s was damaged and irrevocably altered.
Point 1: The Admission
We do not even need to speculate if the mRNA inoculation causes Goldman’s cancer. Roxanne Khamsi leads with the intimation that it did.
The brothers knew this might be just an eerie coincidence. But they couldn’t shake the feeling that Michel had experienced what would be a very rare yet life-threatening side effect of COVID vaccination.
For a lymphoma to follow the injection sites for Michel Goldman’s inoculations and then boosters is a pattern not easily dismissed as mere coincidence, particularly when right after the booster shot Goldman’s lymphoma accelerated rapidly. We may therefore take as stipulated that the inoculation shots are the proximate cause of Goldman’s cancer. This brings us to damning problem number one with the inoculations and their development.
Point 2: T-cell lymphomas and related issues were simply disregarded.
Michel Goldman’s cancer began in certain of his T-cells.
Michel’s cancer was the kind that attacks the body’s T cells, which coordinate the immune response to invading pathogens. T-cell lymphomas come in roughly 30 different subtypes; Michel’s, known as angioimmunoblastic T-cell lymphoma, affects what are called follicular helper T cells, which hang out in the tonsils and the lymph nodes, among other tissues. Follicular helper T cells serve a crucial role in the cascade of events to protect the body after dangerous invaders have arrived. That process begins with dendritic cells, which identify a virus or other pathogen and present examples of it to the rest of the immune system. The helper T cells do just as their name suggests: They help pass that message along to B cells, which end up making protective antibodies against the virus.
As it turns out, the T-cells affected by Goldman’s lymphoma are also affected by the mRNA inoculations. In fact, stimulating these particular T-cells are a documented attribute of mRNA injections that use lipid nanoparticles.
T follicular helper (Tfh) cells are required to develop germinal center (GC) responses and drive immunoglobulin class switch, affinity maturation, and long-term B cell memory. In this study, we characterize a recently developed vaccine platform, nucleoside-modified, purified mRNA encapsulated in lipid nanoparticles (mRNA-LNPs), that induces high levels of Tfh and GC B cells. Intradermal vaccination with nucleoside-modified mRNA-LNPs encoding various viral surface antigens elicited polyfunctional, antigen-specific, CD4+ T cell responses and potent neutralizing antibody responses in mice and nonhuman primates. Importantly, the strong antigen-specific Tfh cell response and high numbers of GC B cells and plasma cells were associated with long-lived and high-affinity neutralizing antibodies and durable protection. Comparative studies demonstrated that nucleoside-modified mRNA-LNP vaccines outperformed adjuvanted protein and inactivated virus vaccines and pathogen infection. The incorporation of noninflammatory, modified nucleosides in the mRNA is required for the production of large amounts of antigen and for robust immune responses.
A key point must be acknowledged by one and all at this juncture: the Pfizer mRNA inoculation is the first and only mRNA inoculation to receive full FDA approval.
This fact matters, because Goldman’s own hypothesis is that this hyperactivation of his T-cells at the very least aggrevated his lymphoma, and may have caused it.
Some researchers argue that the COVID vaccines from Pfizer and Moderna have been more protective than others for exactly this reason: They rev up those cells with extra oomph. Now Michel began to wonder whether that oomph could, in ultrarare cases, turn out to be a liability. Perhaps the shots gave such a jolt to his helper T cells that they went berserk. If they were prone to forming tumors, or if they were already cancerous, then overstimulation could have made the problem even worse.
However, this presents a rather significant ethical problem: The mRNA inoculation clinical trials never examined the risks attendant on hyperstimulation of cancerous or even pre-cancerous T-cells, despite the clear evidence that such hyperstimulation was not merely a known characteristic of the lipid nanoparticle delivery system but an essential “virtue”. Because no other proposed mRNA vaccine product has progressed to stage 3 clinical trials, these risks have never been examined in a proper clinical setting, period. This is not speculation, but demonstrated fact.
That brings us to the next damning problem surrounding the strange case of Michel Goldman’s lymphoma.
Point 3: Pfizer Turned Cancer Patients And Potential Cancer Patients Into Unwitting Guinea Pigs
T-cell lymphomas might be rare, but they are not unknown, even before COVID-19. The attractiveness in using mRNA-LNP to stimulate them demonstrates this absolutely. By extension, the risks of hyperstimulating cancerous and/or pre-cancerous T-cells were also known prior to COVID-19. In fact, prior research specifically established that such hyperstimulation could, under the right circumstances, produce Michel Goldman’s exact type of T-cell lymphoma.
Angioimmunoblastic T cell lymphoma (AITL) is an aggressive tumor derived from malignant transformation of T follicular helper (Tfh) cells. AITL is characterized by loss-of-function mutations in Ten-Eleven Translocation 2 (TET2) epigenetic tumor suppressor and a highly recurrent mutation (p.Gly17Val) in the RHOA small GTPase. Yet, the specific role of RHOA G17V in AITL remains unknown. Expression of Rhoa G17V in CD4+ T cells induces Tfh cell specification; increased proliferation associated with ICOS upregulation and increased PI3K and MAPK signaling. Moreover, RHOA G17V expression together with Tet2 loss resulted in development of AITL in mice. Importantly, Tet2−/− RHOA G17V tumor proliferation in vivo can be inhibited by ICOS/PI3K-specific blockade, supporting a driving role for ICOS signaling in Tfh cell transformation.
Yet Pfizer at no time gave any of this any consideration in its clinical trials. The impacts of the mRNA inoculations on cancer patients were, by even Michel Goldman’s own admission, untested. By definition, that renders every cancer patient receiving the mRNA inoculations today a Pfizer test subject—without their knowledge or their consent.
This is a clear and unequivocal violation of the medical research ethics laid out in the World Medical Association’s Declaration of Helsinki.
Furthermore, even if one rejects the contextualization of administering mRNA inoculations to cancer patients as stealth medical research, to promote such administration generally, as Michel Goldman himself acknowledges doing, along with oncologists as well as the CDC, with demonstrably false statements is a violation of fundamental patient rights—and it is clear that demonstrably false statements were given:
The currently approved mRNA vaccines are safe for cancer patients so long as patients do not have any contraindications, according to the Centers for Disease Control and Prevention (CDC). Contraindications, or conditions that make a particular procedure inadvisable, for the mRNA vaccine include having a severe or immediate allergic reaction (such as anaphylaxis) after a dose of an mRNA COVID-19 vaccine or any of its components (including polyethylene glycol [PEG]).
As Michel Goldman’s case illustrates, a genetic predisposition to T-cell lymphoma is a clear contraindication to receiving the inoculations, as was clearly evident based on prior known research. Thus, even if one presumes the Declaration of Helsinki is not applicable, the rights of the patient for informed consent as laid out in the Declaration of Lisbon are always applicable.
Michel Goldman’s Lymphoma Is A Damning Violation Of Fundamental Medical Ethics
An immunologist’s fervent belief in the ultimate lifesaving value of vaccines does not vitiate the ethical duty of care laid upon all healthcare workers to respect the rights of every patient. Michel Goldman’s extensive resume and experience in vaccine development do not give him leave to decide for each and every patient under the sun what is and is not “safe”. The Declarations of Helsinki and Lisbon exist specifically to express to doctors worldwide that their ethical duties are fundamentally non-negotiable: they are part and parcel of the medical profession.
Previously, I have written on the evils inherent in the ideological perversion of scientific research, which in prior generations was termed “Lysenkoism” and which I have taken the liberty of re-branding for the COVID-19 era as “Faucism”.
Michel Goldman demonstrates in stark terms why Faucism is so dangerous. It leads doctors down the nihilistic path of making choices which lead directly to patient harm and even patient death. Even Roxanne Khamsi acknowledges this, with her closing paragraph:
Around the time of his February follow-up, Michel received a message from a doctor who had read his self-referential case report. The doctor’s mother had been diagnosed with the same subtype of lymphoma that Michel has following a COVID booster shot. More recently, he got an email from a woman whose sister had been vaccinated and received that diagnosis the following month. Again, these could be coincidences. Or maybe they are the second and third data points in a growing set.
Michel Goldman is not an isolated case—nor would it ever have been reasonably expected that he would be an isolated case. The extant clinical research on the use of mRNA-LNP technology to hyperstimulate T-cells and the susceptibility of certain T-cells with particular mutations to turn into cancer cells—all of which predates even the SARS-CoV-2 virus itself—-demonstrates categorically that Michel Goldman’s lymphoma caused by the mRNA inoculations was inevitable. For him and every other potential or existing lymphoma patient with the right genetic mutations, the mRNA inoculations are lethal.
Moreover, both Roxanne Khamsi and Michel Goldman have perverted the concept of “risk assessment”. By itself, this is hardly unusual for the “pro-inoculation” cohort within the healthcare professions, as I have discussed previously.
However, unlike the target of my invective then, they and the CDC at a minimum have unconscionably arrogated to themselves the right to decide what constitutes “unacceptable” risks to the patient. Not only is this contrary to the personal, case-by-case nature of risk assessment, it is yet another violation of fundamental patient rights as outlined in both the Declarations of Helsinki and Lisbon.
It is the complete evisceration of the patient-physician relationship that is made central to both patient rights and medical ethics as outlined in the Declaration of Cordoba.
It is the complete abdication of any notion of medical ethics and integrity as promulgated by the World Medical Association.
Additionally, for those susceptible to T-cell lymphomas, who will develop that particular (and lethal) cancer if they receive the mRNA inoculations, that is not merely misguided “risk assessment”, but arguably negligent homicide.
Again, this is the danger Faucism presents to everyone, and not just surrounding the mRNA inoculations against COVID-19. For doctors and even science journalists to presume to decide what is right and proper for every patient of every physician, completely denying said patients any opportunity to voice their own choices and wishes, is simply barbaric. It is a pharmaceutical authoritarianism that is incompatible with any free people seeking to live within a free society.
I am glad that Michel Goldman is on course to survive his cancer. I do not wish the death of any human being, not even a committed Faucist such as he. However, my prayers for his good health do not extend to sympathy for his plight, nor for the presumed “struggles” of Roxanne Khamsi in writing about it. Given the particulars, given what was known before the inoculations ever existed and what has been learned about their lethality since, his story is neither heroic nor tragic. To the contrary, it is simply disgusting, and I am simply disgusted.
My sympathies are reserved for the untold numbers of human beings already harmed and yet to be harmed by the Michel Goldmans of the medical profession, and their Faucist-fueled rejection of ethics and integrity.
Will Roxanne Khamsi write with equal passion about their pains? Will she be suitably elegiac in covering their deaths? Will she even bother to acknowledge their existence?
Somehow, I think I already know the answer. I think you do, too.
All Facts Matter is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Alternatively, please consider leaving a tip on Ko-Fi. Thank you always for your support!
Pardi, Norbert et al. “Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses.” The Journal of experimental medicine vol. 215,6 (2018): 1571-1588. doi:10.1084/jem.20171450
Cortes, Jose R et al. “RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis.” Cancer cell vol. 33,2 (2018): 259-273.e7. doi:10.1016/j.ccell.2018.01.001